Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Nebivolol 5 mg + Hydrochlorothiazide 12.5 mg Tablet
Therapeutic Category
Hypertension/ Blood Pressure, Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹155/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
This tablet is a combination medicine used to control high blood pressure (hypertension). Nebivolol is a beta-blocker that slows the heart rate and relaxes blood vessels, while Hydrochlorothiazide is a diuretic (water pill) that helps remove extra salt and water from the body. Together, they lower blood pressure more effectively, reduce strain on the heart, and help prevent heart attacks, strokes, and kidney problems caused by uncontrolled hypertension.
Common side effects include dizziness, tiredness, headache, increased urination, dehydration, and low blood pressure. Rarely, it may cause changes in electrolytes (like low potassium or sodium), slow heartbeat, or allergic reactions.
Used to treat high blood pressure in patients who need combination therapy to achieve better control.
Take this medicine exactly as prescribed by your doctor. Do not stop suddenly, as it may cause a sudden rise in blood pressure. Regular blood pressure checks and blood tests may be needed to monitor electrolytes and kidney function. Inform your doctor if you are pregnant, breastfeeding, or have kidney, liver, or heart problems.
Store in a cool, dry place below 30°C, away from moisture and sunlight. Keep out of reach of children and use only up to the expiry date.
Composition : Nebivolol 2.5 mg Tablet
Composition : Nebivolol 5 mg Tablet
Composition : Telmisartan 40 mg + Nebivolol 5 mg Tablet
Composition : Nebivolol 5 mg + Amlodipine 5 mg Tablet
Composition : Nebivolol 2.5 mg + Cilnidipine 10 mg Tablet
Composition : Nebivolol 5 mg + Cilnidipine 10 mg Tablet
Composition : Nicorandil (5mg) Tablet
Composition : Nicorandil 10 mg Tablet
Composition : Nitroglycerine 2.6 mg Tablet
Composition : Nitroglycerine 6.4 mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Nebivolol 5 mg + Hydrochlorothiazide 12.5 mg Tablet is a combination antihypertensive medication used for the management of high blood pressure (hypertension) and cardiovascular risk reduction. Nebivolol is a beta-blocker that helps regulate heart rate and blood pressure, while Hydrochlorothiazide is a diuretic that helps remove excess fluid and sodium from the body. This combination is widely prescribed in the cardiac and cardiovascular care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from cardiologists, physicians, and healthcare practitioners. As hypertension is a chronic condition requiring long-term treatment, combination therapies such as Nebivolol and Hydrochlorothiazide generate regular prescriptions, repeat purchases, and stable market demand.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiac and cardiovascular segment with monopoly rights, quality-assured manufacturing, attractive promotional support, and reliable product supply for distributors and franchise partners.
Wholesalers and distributors benefit from strong prescription volume, long-term patient adherence, increasing prevalence of hypertension, and continuous demand from healthcare institutions, making this product a profitable and sustainable addition to their pharmaceutical portfolio when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in cardiac and antihypertensive formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, promotional support, and PCD pharma franchise opportunities in the cardiovascular care segment.